Evidence map›Paper›PMID 36652137›Full record

SynthesisJournal of thrombosis and thrombolysis2023

Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis.

Marco Zuin, Stefano Barco, George Giannakoulas, Matthias M Engelen, Lukas Hobohm, Luca Valerio, Christophe Vandenbriele, Peter Verhamme, Thomas Vanassche, Stavros V Konstantinides

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of thrombosis and thrombolysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Pooled it
  4. Review
  5. Review
  6. Article
  7. Temporal Trends in Pulmonary Embolism Mortality Associated with COVID-19 in the United States: A 5-Year Retrospective Analysis.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Psychological Impact of Pulmonary Embolism: A Narrative Review.Journal of community hospital internal medicine perspectives · 2025
    Review
  15. Thromboembolic Events in the Era of COVID-19: A Detailed Narrative Review.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  16. Article
  17. Review
  18. COVID-19: a vascular nightmare unfolding.Frontiers in immunology · 2025
    Review
  19. Translating insights into therapies for Long Covid.Science translational medicine · 2024
    Review
  20. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Marco ZuinDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. zuinml@yahoo.it.ORCID http://orcid.org/0000-0002-4559-1292
Stefano BarcoDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.
George GiannakoulasDepartment of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Matthias M EngelenDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Lukas HobohmCenter for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany.
Luca ValerioCenter for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany.
Christophe VandenbrieleDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Peter VerhammeDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Thomas VanasscheDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Stavros V KonstantinidesCenter for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany.
KU Leuven · BEJohannes Gutenberg University Mainz · DEAristotle University of Thessaloniki · GRDemocritus University of Thrace · GRUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data regarding the occurrence of venous thromboembolic events (VTE), including acute pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients are scant. We performed a systematic review and meta-analysis to assess the risk of acute PE and DVT in COVID-19 recovered subject. Following the PRIMSA guidelines, we searched Medline and Scopus to locate all articles published up to September 1st, 2022, reporting the risk of acute PE and/or DVT in patients recovered from COVID-19 infection compared to non-infected patients who developed VTE over the same follow-up period. PE and DVT risk were evaluated using the Mantel-Haenszel random effects models with Hazard ratio (HR) as the effect measure with 95% confidence interval (CI) while heterogeneity was assessed using Higgins I

Indexed as

COVID-19Pulmonary EmbolismVenous ThromboembolismVenous ThrombosisFemaleHumansMaleMiddle AgedRiskCOVID-19Deep vein thrombosisPulmonary embolismVenous thromboembolism

Identifiers

PMID36652137
PMCPMC9845812
OpenAlexW4317107833

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.